Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGFR | P43088 | 15/20 | 0.78 |
| ▸ | PTGER3 | P43115 | 8/20 | 0.78 |
| ▸ | TBXA2R | P21731 | 5/20 | 0.78 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.78 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.70 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.57 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.57 |
| ▸ | SLCO2A1 | Q92959 | 1/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiaprost SCHEMBL12495592 | 1.00 | PTGFR (0.78) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Tiaprost SCHEMBL12708340 | 1.00 | PTGFR (0.78) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Tiaprost SCHEMBL14511288 | 1.00 | PTGFR (0.78) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Tiaprost SCHEMBL12495595 | 1.00 | PTGFR (0.78) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL10024575 | 0.88 | PTGFR (0.63) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL10057560 | 0.88 | PTGFR (0.63) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL20573392 | 0.88 | PTGFR (1.00) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL13399717 | 0.88 | PTGFR (1.00) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL3368370 | 0.88 | PTGFR (1.00) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL3368364 | 0.88 | PTGFR (1.00) | PTGFRPTGER3TBXA2RPTGER1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 639 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160113942-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2016-04-28 | — | — | US | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| EP-2667875-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | Inceptum Research & Therapeutics, Inc. (CA) | 2013-12-04 | — | — | EP | claimed |
| US-20130309330-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2013-11-21 | — | — | US | claimed |
| US-20130189368-A1 | NANOPARTICULATE COMPOSITION CONTAINING ANTIBIOTICS FOR INTRAMAMMARY ADMINISTRATION IN ANIMALS | UNIVERSIDADE FEDERAL DE OURO PRETO (BR) | 2013-07-25 | — | — | US | claimed |
| CN-103118670-A | Nanoparticle compositions containing antibiotics for intramammary administration in animals | UNIV FED OURO PRETO | 2013-05-22 | — | — | CN | claimed |
| EP-2578209-A1 | NANOPARTICULATE COMPOSITION CONTAINING ANTIBIOTICS FOR INTRAMAMMARY ADMINISTRATION IN ANIMALS | Universidade Federal De Ouro Preto (BR) | 2013-04-10 | — | — | EP | claimed |
| WO-2012100347-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2012-08-02 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| WO-2009154810-A2 | DELIVERY SYSTEMS FOR MULTIPLE ACTIVE AGENTS | DR. REDDY'S LABORATORIES LTD. (IN) | 2009-12-23 | — | — | WO | claimed |
| US-5820587-A | Method and kit for preventing erectile dysfunction | VIVUS INCORPORATED (US) | 1998-10-13 | — | — | US | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| EP-0664707-B1 | COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA | ALCON LAB INC (US) | 1997-06-04 | — | — | EP | claimed |
| US-5605922-A | VISION DISORDERS; SIDE EFFECT REDUCTION | ALCON LABORATORIES, INC. (US) | 1997-02-25 | — | — | US | claimed |
| US-5565492-A | Prostaglandin combinations in glaucoma therapy | ALCON LABORATORIES, INC. (US) | 1996-10-15 | — | — | US | claimed |
| WO-1996013267-A2 | COMBINATIONS OF PROSTAGLANDINS AND BRIMONIDINE OR DERIVATIVES THEREOF FOR THE TREATMENT OF GLAUCOMA | ALLERGAN (US) | 1996-05-09 | — | — | WO | claimed |
| US-5480900-A | Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma | ALCON LABORATORIES, INC. (US) | 1996-01-02 | — | — | US | claimed |
| EP-0664707-A1 | COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA. | ALCON LAB INC (US) | 1995-08-02 | — | — | EP | claimed |
| EP-0603800-A1 | Prostaglandin combinations in glaucoma therapy | ALCON LABORATORIES, INC. (US) | 1994-06-29 | — | — | EP | claimed |
| WO-1994008585-A1 | COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA | ALCON LABORATORIES, INC. (US) | 1994-04-28 | — | — | WO | claimed |